Abstract
Prevention of early recurrent ischaemic stroke remains a priority in people with TIA or ischaemic stroke. A number of trials have recently been completed assessing the efficacy of short-term dual antiplatelet therapy (DAPT) versus single antiplatelet therapy early after minor or moderate stroke or high-risk TIA. We present an Expedited Recommendation for use of dual antiplatelet therapy early after ischaemic stroke and TIA on behalf of the ESO Guideline Board. We make a strong recommendation based on high quality of evidence for use of 21-days of dual antiplatelet therapy with aspirin and clopidogrel in people with a non-cardioembolic minor ischaemic stroke or high-risk TIA in the past 24 hours. We make a weak recommendation based on moderate quality evidence for 30-days of dual antiplatelet therapy with aspirin and ticagrelor in people with non-cardioembolic mild to moderate ischaemic stroke or high-risk TIA in the past 24 hours.
Highlights
Prevention of early recurrent ischaemic stroke remains a priority in people with TIA or ischaemic stroke
Minor ischaemic stroke was defined as NIHSS of 3 or less in the POINT and CHANCE trials and high-risk TIA as an ABCD2 score of 4 or more
Significantly reduced the risk of ischaemic stroke at 90 days (RR 0.70, 95% CI 0.61 to 0.81, I2 1⁄4 0%, absolute reduction 2.6%, high quality evidence, n 1⁄4 2 trials, 10051 participants)
Summary
Prevention of early recurrent ischaemic stroke remains a priority in people with TIA or ischaemic stroke. A number of trials have recently been completed assessing the efficacy of short-term dual antiplatelet therapy (DAPT) versus single antiplatelet therapy early after minor or moderate stroke and high-risk TIA. The role of dual antiplatelet treatment will be considered in both the European Stroke Organisation’s guidelines for management of TIA and guidelines for secondary prevention of ischaemic stroke, yet their use is rapidly increasing. In advance of their publication, we present an Expedited Recommendation for use of dual antiplatelet therapy early after minor ischaemic stroke and TIA on behalf of the ESO Guideline Board. We considered evidence for use of DAPT early after minor or moderate ischaemic stroke and high-risk TIA. We considered DAPT with clopidogrel and aspirin separately from DAPT with ticagrelor and aspirin
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.